Timothy Daley
Stock Analyst at Wells Fargo
(2.02)
# 3,040
Out of 5,142 analysts
58
Total ratings
54.29%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $44 | $47.45 | -6.30% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $4.38 | +356.62% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $97.12 | -2.18% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $39.56 | +82.00% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $124.20 | +16.75% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,393.24 | -6.69% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $327.78 | -13.05% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $210.92 | +17.11% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $163.52 | +68.18% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $285.30 | -5.36% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $11.09 | +152.48% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $16.04 | +118.20% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $516.44 | +0.69% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $0.28 | +3,137.41% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $135.40 | +36.63% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $75.44 | +12.67% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $162.31 | +35.54% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $104.66 | +110.20% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $8.89 | +214.96% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $207.43 | -32.51% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $54.76 | +64.35% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $44
Current: $47.45
Upside: -6.30%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $4.38
Upside: +356.62%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $97.12
Upside: -2.18%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $39.56
Upside: +82.00%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $124.20
Upside: +16.75%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,393.24
Upside: -6.69%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $327.78
Upside: -13.05%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $210.92
Upside: +17.11%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $163.52
Upside: +68.18%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $285.30
Upside: -5.36%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $11.09
Upside: +152.48%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $16.04
Upside: +118.20%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $516.44
Upside: +0.69%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $0.28
Upside: +3,137.41%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $135.40
Upside: +36.63%
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $75.44
Upside: +12.67%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $162.31
Upside: +35.54%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $104.66
Upside: +110.20%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $8.89
Upside: +214.96%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $207.43
Upside: -32.51%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $54.76
Upside: +64.35%